Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes
- PMID: 1610295
- DOI: 10.1007/BF01973627
Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes
Abstract
The effects of bezafibrate administered at 10 and 50 mg/kg/day for 7 days to male Sprague-Dawley (SD) and Lewis rats were investigated in order to determine the interrelation between the changes in serum and hepatic lipid contents and activities of selected peroxisomal, microsomal and mitochondrial enzymes in the two rat strains. In both strains, bezafibrate effectively reduced serum and hepatic lipids, increased the liver weight, induced a proliferation of peroxisomes, and selectively elevated the activities of carnitine acetyltransferase and of the enzymes of the peroxisomal beta-oxidation system. Moreover, immunoblotting revealed that the drug specifically enhanced the concentration of only those peroxisomal enzymes involved in fatty acid beta-oxidation. The data obtained demonstrate that although the responses initiated by bezafibrate are qualitatively similar in both strains, they differ in their magnitude in a dose-dependent manner, with the Lewis strain exhibiting a more pronounced response than the SD rats. These results show that dose-dependent strain differences as well as the generally known species differences should be taken into account in pharmacological and toxicological evaluations of fibrates in rodents. Furthermore, generalization and extrapolation from rodent studies should be treated with great caution.
Similar articles
-
Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.Br J Pharmacol. 1994 Jun;112(2):551-6. doi: 10.1111/j.1476-5381.1994.tb13109.x. Br J Pharmacol. 1994. PMID: 7915611 Free PMC article.
-
Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.Toxicol Appl Pharmacol. 1997 Jan;142(1):143-50. doi: 10.1006/taap.1996.8007. Toxicol Appl Pharmacol. 1997. PMID: 9007043
-
Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.FEBS Lett. 1990 May 7;264(1):5-9. doi: 10.1016/0014-5793(90)80750-d. FEBS Lett. 1990. PMID: 2338145
-
Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease.Crit Rev Toxicol. 1998 Jan;28(1):1-33. doi: 10.1080/10408449891344182. Crit Rev Toxicol. 1998. PMID: 9493760 Review.
-
Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.Food Cosmet Toxicol. 1981 Oct;19(5):585-605. doi: 10.1016/0015-6264(81)90509-5. Food Cosmet Toxicol. 1981. PMID: 7030887 Review. No abstract available.
Cited by
-
Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.Br J Pharmacol. 1994 Jun;112(2):551-6. doi: 10.1111/j.1476-5381.1994.tb13109.x. Br J Pharmacol. 1994. PMID: 7915611 Free PMC article.
-
Strain-dependent urethral response.Neurourol Urodyn. 2011 Nov;30(8):1652-8. doi: 10.1002/nau.21158. Epub 2011 Aug 8. Neurourol Urodyn. 2011. PMID: 21826722 Free PMC article.
-
Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.PLoS One. 2014 Apr 23;9(4):e96056. doi: 10.1371/journal.pone.0096056. eCollection 2014. PLoS One. 2014. PMID: 24759758 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical